{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T06:00:49Z","timestamp":1794031249348,"version":"4.8.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T00:00:00Z","timestamp":1758326400000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["189963"],"award-info":[{"award-number":["189963"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Rare Disease Research Alliance","award":["101156595"],"award-info":[{"award-number":["101156595"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s00415-025-13387-4","type":"journal-article","created":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:49:48Z","timestamp":1758361788000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Delineating the pathogenic threshold and phenotypic spectrum of SCA27B: findings from a large French\u2013Canadian cohort"],"prefix":"10.1007","volume":"272","author":[{"given":"Pablo","family":"Iruzubieta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Pellerin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Ashton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Renaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Jos\u00e9e","family":"Dicaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt C.","family":"Danzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayra","family":"Aldecoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Massie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin H.","family":"Chalk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Louise","family":"Lafontaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Evoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-France","family":"Rioux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Denis","family":"Brisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kym M.","family":"Boycott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Houlden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthis","family":"Synofzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"La Piana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Zuchner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Duquette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Brais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,20]]},"reference":[{"key":"13387_CR1","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1002\/ana.27060","volume":"96","author":"W Abou Chaar","year":"2024","unstructured":"Abou Chaar W, Eranki AN, Stevens HA et al (2024) Clinical, radiological and pathological features of a large American cohort of spinocerebellar ataxia ( sca27b ). Ann Neurol 96:1092\u20131103. https:\/\/doi.org\/10.1002\/ana.27060","journal-title":"Ann Neurol"},{"key":"13387_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/braincomms\/fcad239","volume":"5","author":"C Ashton","year":"2023","unstructured":"Ashton C, Indelicato E, Pellerin D et al (2023) Spinocerebellar ataxia 27B: episodic symptoms and acetazolamide response in 34 patients. Brain Commun 5:1\u20135. https:\/\/doi.org\/10.1093\/braincomms\/fcad239","journal-title":"Brain Commun"},{"key":"13387_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.70016","author":"A Cuillerier","year":"2025","unstructured":"Cuillerier A, Del Gobbo GF, Mackay L et al (2025) fgf14 gaa intronic expansion in unsolved adult-onset ataxia in the care4rare Canada consortium. Ann Clin Transl Neurol. https:\/\/doi.org\/10.1002\/acn3.70016","journal-title":"Ann Clin Transl Neurol"},{"key":"13387_CR4","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1002\/mds.29559","volume":"38","author":"H Hengel","year":"2023","unstructured":"Hengel H, Pellerin D, Wilke C et al (2023) As frequent as polyglutamine spinocerebellar ataxias: SCA27B in a large German autosomal dominant ataxia cohort. Mov Disord 38:1557\u20131558. https:\/\/doi.org\/10.1002\/mds.29559","journal-title":"Mov Disord"},{"key":"13387_CR5","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.1111\/ene.16039","volume":"30","author":"P Iruzubieta","year":"2023","unstructured":"Iruzubieta P, Pellerin D, Bergareche A et al (2023) Frequency and phenotypic spectrum of spinocerebellar ataxia 27B and other genetic ataxias in a Spanish cohort of late-onset cerebellar ataxia. Eur J Neurol 30:3828\u20133833. https:\/\/doi.org\/10.1111\/ene.16039","journal-title":"Eur J Neurol"},{"key":"13387_CR6","doi-asserted-by":"publisher","DOI":"10.1111\/cge.14482","author":"C Kartanou","year":"2024","unstructured":"Kartanou C, Mitrousias A, Pellerin D et al (2024) The FGF14 GAA repeat expansion in Greek patients with late-onset cerebellar ataxia and an overview of the SCA27B phenotype across populations. Clin Genet. https:\/\/doi.org\/10.1111\/cge.14482","journal-title":"Clin Genet"},{"key":"13387_CR7","doi-asserted-by":"publisher","first-page":"fcae479","DOI":"10.1093\/braincomms\/fcae479","volume":"7","author":"I Livanos","year":"2024","unstructured":"Livanos I, Votsi C, Michailidou K et al (2024) The FGF14 GAA repeat expansion is a major cause of ataxia in the Cypriot population. Brain Commun 7:fcae479. https:\/\/doi.org\/10.1093\/braincomms\/fcae479","journal-title":"Brain Commun"},{"key":"13387_CR8","doi-asserted-by":"publisher","first-page":"104931","DOI":"10.1016\/j.ebiom.2023.104931","volume":"99","author":"J-L M\u00e9reaux","year":"2024","unstructured":"M\u00e9reaux J-L, Davoine C-S, Pellerin D et al (2024) Clinical and genetic keys to cerebellar ataxia due to FGF14 GAA expansions. EBioMedicine 99:104931. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104931","journal-title":"EBioMedicine"},{"key":"13387_CR9","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1002\/mdc3.14020","volume":"11","author":"A Milovanovi\u0107","year":"2024","unstructured":"Milovanovi\u0107 A, Draga\u0161evic-Mi\u0161kovi\u0107 N, Thomsen M et al (2024) RFC1 and fgf14 repeat expansions in Serbian patients with cerebellar ataxia. Mov Disord Clin Pract 11:626\u2013633. https:\/\/doi.org\/10.1002\/mdc3.14020","journal-title":"Mov Disord Clin Pract"},{"key":"13387_CR10","doi-asserted-by":"publisher","first-page":"e200094","DOI":"10.1212\/NXG.0000000000200094","volume":"9","author":"LE Novis","year":"2023","unstructured":"Novis LE, Frezatti RS, Pellerin D et al (2023) Frequency of GAA-FGF14 ataxia in a large cohort of Brazilian patients with unsolved adult-onset cerebellar ataxia. Neurol Genet 9:e200094. https:\/\/doi.org\/10.1212\/NXG.0000000000200094","journal-title":"Neurol Genet"},{"key":"13387_CR11","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1056\/NEJMoa2207406","volume":"388","author":"D Pellerin","year":"2023","unstructured":"Pellerin D, Danzi MC, Wilke C et al (2023) Deep intronic FGF14 GAA repeat expansion in late-onset cerebellar ataxia. N Engl J Med 388:128\u2013141. https:\/\/doi.org\/10.1056\/NEJMoa2207406","journal-title":"N Engl J Med"},{"key":"13387_CR12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11910-024-01400-8","volume":"25","author":"D Pellerin","year":"2025","unstructured":"Pellerin D, Iruzubieta P, Xu IRL et al (2025) Recent advances in the genetics of ataxias: an update on novel autosomal dominant repeat expansions. Curr Neurol Neurosci Rep 25:16. https:\/\/doi.org\/10.1007\/s11910-024-01400-8","journal-title":"Curr Neurol Neurosci Rep"},{"key":"13387_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ajhg.2022.11.015","volume":"110","author":"H Rafehi","year":"2023","unstructured":"Rafehi H, Read J, Szmulewicz DJ et al (2023) An intronic GAA repeat expansion in FGF14 causes the autosomal-dominant adult-onset ataxia SCA27B\/ATX-FGF14. Am J Hum Genet 110:105\u2013119. https:\/\/doi.org\/10.1016\/j.ajhg.2022.11.015","journal-title":"Am J Hum Genet"},{"key":"13387_CR14","doi-asserted-by":"publisher","first-page":"5478","DOI":"10.1007\/s00415-024-12506-x","volume":"271","author":"S Satolli","year":"2024","unstructured":"Satolli S, Rossi S, Vegezzi E et al (2024) Spinocerebellar ataxia 27B: a frequent and slowly progressive autosomal-dominant cerebellar ataxia\u2014experience from an Italian cohort. J Neurol 271:5478\u20135488. https:\/\/doi.org\/10.1007\/s00415-024-12506-x","journal-title":"J Neurol"},{"key":"13387_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awad157","author":"C Wilke","year":"2023","unstructured":"Wilke C, Pellerin D, Mengel D et al (2023) GAA-FGF14 ataxia (SCA27B): phenotypic profile, natural history progression and 4-aminopyridine treatment response. Brain. https:\/\/doi.org\/10.1093\/brain\/awad157","journal-title":"Brain"},{"key":"13387_CR16","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1002\/mds.29560","volume":"38","author":"T Wirth","year":"2023","unstructured":"Wirth T, Cl\u00e9ment G, Delvall\u00e9e C et al (2023) Natural history and phenotypic spectrum of GAA-FGF14 sporadic late-onset cerebellar ataxia (SCA27B). Mov Disord 38:1950\u20131956. https:\/\/doi.org\/10.1002\/mds.29560","journal-title":"Mov Disord"},{"key":"13387_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51936","author":"M Ando","year":"2023","unstructured":"Ando M, Higuchi Y, Yuan J et al (2023) Clinical variability associated with intronic FGF14 GAA repeat expansion in Japan. Ann Clin Transl Neurol. https:\/\/doi.org\/10.1002\/acn3.51936","journal-title":"Ann Clin Transl Neurol"},{"key":"13387_CR18","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1136\/jnnp-2024-333541","volume":"95","author":"S Miyatake","year":"2024","unstructured":"Miyatake S, Doi H, Yaguchi H et al (2024) Complete nanopore repeat sequencing of SCA27B (GAA- FGF14 ataxia) in Japanese. J Neurol Neurosurg Psychiatry 95:1187\u20131195. https:\/\/doi.org\/10.1136\/jnnp-2024-333541","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13387_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s10038-023-01200-x","volume":"69","author":"K Mizushima","year":"2024","unstructured":"Mizushima K, Shibata Y, Shirai S et al (2024) Prevalence of repeat expansions causing autosomal dominant spinocerebellar ataxias in Hokkaido, the northernmost island of Japan. J Hum Genet 69:27\u201331. https:\/\/doi.org\/10.1038\/s10038-023-01200-x","journal-title":"J Hum Genet"},{"key":"13387_CR20","doi-asserted-by":"publisher","first-page":"105077","DOI":"10.1016\/j.ebiom.2024.105077","volume":"102","author":"R Ouyang","year":"2024","unstructured":"Ouyang R, Wan L, Pellerin D et al (2024) The genetic landscape and phenotypic spectrum of GAA-FGF14 ataxia in China: a large cohort study. EBioMedicine 102:105077. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105077","journal-title":"EBioMedicine"},{"key":"13387_CR21","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s10038-024-01262-5","volume":"69","author":"Z-H Zheng","year":"2024","unstructured":"Zheng Z-H, Cao C-Y, Cheng B et al (2024) Characteristics of tandem repeat inheritance and sympathetic nerve involvement in GAA-FGF14 ataxia. J Hum Genet 69:433\u2013440. https:\/\/doi.org\/10.1038\/s10038-024-01262-5","journal-title":"J Hum Genet"},{"key":"13387_CR22","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1002\/mds.29915","volume":"39","author":"D Pellerin","year":"2024","unstructured":"Pellerin D, Seemann J, Trasch\u00fctz A et al (2024) Reduced age-dependent penetrance of a large fgf14 gaa repeat expansion in a 74-year-old woman from a German family with sca27b. Mov Disord 39:1892\u20131894. https:\/\/doi.org\/10.1002\/mds.29915","journal-title":"Mov Disord"},{"key":"13387_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s12311-025-01882-3","author":"LA Rettenmaier","year":"2025","unstructured":"Rettenmaier LA (2025) Spinocerebellar ataxia type 27B can be suspected based on clinical phenotype: the Massachusetts General Hospital ataxia center experience. Cerebellum. https:\/\/doi.org\/10.1007\/s12311-025-01882-3","journal-title":"Cerebellum"},{"key":"13387_CR24","doi-asserted-by":"publisher","first-page":"7665","DOI":"10.1038\/s41467-024-52148-1","volume":"15","author":"L Mohren","year":"2024","unstructured":"Mohren L, Erdlenbruch F, Leit\u00e3o E et al (2024) Identification and characterisation of pathogenic and non-pathogenic FGF14 repeat expansions. Nat Commun 15:7665. https:\/\/doi.org\/10.1038\/s41467-024-52148-1","journal-title":"Nat Commun"},{"key":"13387_CR25","doi-asserted-by":"publisher","first-page":"e200118","DOI":"10.1212\/NXG.0000000000200118","volume":"10","author":"C Foucard","year":"2024","unstructured":"Foucard C, Belley M, Sangare A et al (2024) Paroxysmal ataxia. Neurol Genet 10:e200118. https:\/\/doi.org\/10.1212\/NXG.0000000000200118","journal-title":"Neurol Genet"},{"key":"13387_CR26","doi-asserted-by":"publisher","first-page":"5629","DOI":"10.1007\/s00415-023-11868-y","volume":"270","author":"J Seemann","year":"2023","unstructured":"Seemann J, Trasch\u00fctz A, Ilg W, Synofzik M (2023) 4-aminopyridine improves real-life gait performance in SCA27B on a single-subject level: a prospective n-of-1 treatment experience. J Neurol 270:5629\u20135634. https:\/\/doi.org\/10.1007\/s00415-023-11868-y","journal-title":"J Neurol"},{"key":"13387_CR27","doi-asserted-by":"publisher","first-page":"e1504","DOI":"10.1002\/ctm2.1504","volume":"14","author":"D Pellerin","year":"2024","unstructured":"Pellerin D, Danzi MC, Renaud M et al (2024) Spinocerebellar ataxia 27B: a novel, frequent and potentially treatable ataxia. Clin Transl Med 14:e1504. https:\/\/doi.org\/10.1002\/ctm2.1504","journal-title":"Clin Transl Med"},{"key":"13387_CR28","doi-asserted-by":"publisher","first-page":"105715","DOI":"10.1016\/j.ebiom.2025.105715","volume":"115","author":"D Beijer","year":"2025","unstructured":"Beijer D, Mengel D, \u00d6nder D et al (2025) The genetic landscape of sporadic adult-onset degenerative ataxia: a multi-modal genetic study of 377 consecutive patients from the longitudinal multi-centre SPORTAX cohort. EBioMedicine 115:105715. https:\/\/doi.org\/10.1016\/j.ebiom.2025.105715","journal-title":"EBioMedicine"},{"key":"13387_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105076","author":"D Pellerin","year":"2024","unstructured":"Pellerin D, Heindl F, Wilke C et al (2024) GAA-FGF14 disease: defining its frequency, molecular basis, and 4-aminopyridine response in a large downbeat nystagmus cohort. EBioMedicine. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105076","journal-title":"EBioMedicine"},{"key":"13387_CR30","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1038\/s41588-024-01808-5","volume":"56","author":"D Pellerin","year":"2024","unstructured":"Pellerin D, Del Gobbo GF, Couse M et al (2024) A common flanking variant is associated with enhanced stability of the FGF14-SCA27B repeat locus. Nat Genet 56:1366\u20131370. https:\/\/doi.org\/10.1038\/s41588-024-01808-5","journal-title":"Nat Genet"},{"key":"13387_CR31","doi-asserted-by":"crossref","unstructured":"Pellerin D, M\u00e9reaux J-L, Boluda S, et al (2024) Somatic instability of the FGF14-SCA27B GAA\u2022TTC repeat 2 reveals a marked expansion bias in the cerebellum","DOI":"10.1101\/2024.07.01.24309777"},{"key":"13387_CR32","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/mds.29005","volume":"37","author":"GK Wenning","year":"2022","unstructured":"Wenning GK, Stankovic I, Vignatelli L et al (2022) The movement disorder society criteria for the diagnosis of multiple system atrophy. Mov Disord 37:1131\u20131148. https:\/\/doi.org\/10.1002\/mds.29005","journal-title":"Mov Disord"},{"key":"13387_CR33","doi-asserted-by":"publisher","first-page":"9737","DOI":"10.1038\/s41598-023-36654-8","volume":"13","author":"C Bonnet","year":"2023","unstructured":"Bonnet C, Pellerin D, Roth V et al (2023) Optimized testing strategy for the diagnosis of GAA-FGF14 ataxia\/spinocerebellar ataxia 27B. Sci Rep 13:9737. https:\/\/doi.org\/10.1038\/s41598-023-36654-8","journal-title":"Sci Rep"},{"key":"13387_CR34","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1212\/01.wnl.0000219042.60538.92","volume":"66","author":"T Schmitz-H\u00fcbsch","year":"2006","unstructured":"Schmitz-H\u00fcbsch T, du Montcel ST, Baliko L et al (2006) Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology 66:1717\u20131720. https:\/\/doi.org\/10.1212\/01.wnl.0000219042.60538.92","journal-title":"Neurology"},{"key":"13387_CR35","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1093\/brain\/awp211","volume":"132","author":"M Anheim","year":"2009","unstructured":"Anheim M, Monga B, Fleury M et al (2009) Ataxia with oculomotor apraxia type 2: clinical, biological and genotype\/phenotype correlation study of a cohort of 90 patients. Brain 132:2688\u20132698. https:\/\/doi.org\/10.1093\/brain\/awp211","journal-title":"Brain"},{"key":"13387_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-025-12964-x","author":"D Gen\u00eds","year":"2025","unstructured":"Gen\u00eds D, Alemany B, Pellerin D et al (2025) Late-onset vestibulocerebellar ataxia: clinical and genetic studies in a long follow-up series of 50 patients. J Neurol. https:\/\/doi.org\/10.1007\/s00415-025-12964-x","journal-title":"J Neurol"},{"key":"13387_CR37","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1002\/mds.29552","volume":"38","author":"D Pellerin","year":"2023","unstructured":"Pellerin D, Iruzubieta P, Tekg\u00fcl \u015e et al (2023) Non-GAA repeat expansions in FGF14 are likely not pathogenic\u2014reply to: \u201cshaking up ataxia: FGF14 and RFC1 repeat expansions in affected and unaffected members of a Chilean fam. Mov Disord 38:1575\u20131577. https:\/\/doi.org\/10.1002\/mds.29552","journal-title":"Mov Disord"},{"key":"13387_CR38","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-025-13234-6","author":"A Hocquel","year":"2025","unstructured":"Hocquel A, Pellerin D, M\u00e9reaux JL et al (2025) Late-onset cerebellar ataxia in three European patients with repeat expansions in RFC1 and FGF14: a case series. J Neurol. https:\/\/doi.org\/10.1007\/s00415-025-13234-6","journal-title":"J Neurol"},{"key":"13387_CR39","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaf183","author":"J La\u00df","year":"2025","unstructured":"La\u00df J, Thomsen M, Borsche M et al (2025) FGF14 repeat length and mosaic interruptions: modifiers of spinocerebellar ataxia 27B? Brain J Neurol. https:\/\/doi.org\/10.1093\/brain\/awaf183","journal-title":"Brain J Neurol"},{"key":"13387_CR40","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/ejhg.2014.138","volume":"23","author":"F Morales","year":"2015","unstructured":"Morales F, V\u00e1squez M, Cuenca P et al (2015) Parental age effects, but no evidence for an intrauterine effect in the transmission of myotonic dystrophy type 1. Eur J Hum Genet 23:646\u2013653. https:\/\/doi.org\/10.1038\/ejhg.2014.138","journal-title":"Eur J Hum Genet"},{"key":"13387_CR41","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1093\/hmg\/ddq015","volume":"19","author":"C Braida","year":"2010","unstructured":"Braida C, Stefanatos RKA, Adam B et al (2010) Variant CCG and GGC repeats within the CTG expansion dramatically modify mutational dynamics and likely contribute toward unusual symptoms in some myotonic dystrophy type 1 patients. Hum Mol Genet 19:1399\u20131412. https:\/\/doi.org\/10.1093\/hmg\/ddq015","journal-title":"Hum Mol Genet"},{"key":"13387_CR42","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.mcn.2009.05.007","volume":"42","author":"F Laezza","year":"2009","unstructured":"Laezza F, Lampert A, Kozel MA et al (2009) FGF14 n-terminal splice variants differentially modulate Nav1.2 and Nav1.6-encoded sodium channels. Mol Cell Neurosci 42:90\u2013101. https:\/\/doi.org\/10.1016\/j.mcn.2009.05.007","journal-title":"Mol Cell Neurosci"},{"key":"13387_CR43","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0896-6273(02)00744-4","volume":"35","author":"Q Wang","year":"2002","unstructured":"Wang Q, Bardgett ME, Wong M et al (2002) Ataxia and paroxysmal dyskinesia in mice lacking axonally transported FGF14. Neuron 35:25\u201338. https:\/\/doi.org\/10.1016\/S0896-6273(02)00744-4","journal-title":"Neuron"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13387-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13387-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13387-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:35:33Z","timestamp":1760524533000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13387-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["13387"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13387-4","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Matthis Synofzik has received consultancy honoraria from Ionis, UCB, Prevail, Orphazyme, Biogen, Servier, Reata, GenOrph, AviadoBio, Biohaven, Zevra, Lilly, Quince, Neurocrine, and Solaxa, all unrelated to the present manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki. The institutional review board of the Montreal Neurological Hospital (MPE-CUSM-15\u2013915 and CHUM-ND02.045) approved this study and all participants provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"636"}}